In 2018, Wingtech Technology’s acquisition of the Dutch semiconductor giant Nexperia was hailed as a masterstroke of Chinese industrial ambition. The deal, valued at over 30 billion yuan (approximately $4.2 billion), was a classic 'snake swallows elephant' maneuver that propelled the former contract manufacturer into the global semiconductor elite. At its peak, Wingtech was a darling of the A-share market, boasting a valuation exceeding 200 billion yuan and representing the tip of the spear for China’s domestic chip strategy.
However, that triumph has curdled into a corporate catastrophe. By late 2025, a sudden intervention by the Dutch government, citing national security concerns, froze Nexperia’s global assets and intellectual property. This administrative move effectively decapitated Wingtech’s control over its most valuable offshore asset, sending the company's stock into a tailspin that wiped out over 10 billion yuan in market value in a single weekend.
The crisis escalated into a full-blown internal revolt when Nexperia’s foreign executives successfully sued their Chinese parent company in a Dutch court. Without a full hearing, the court stripped Wingtech founder Zhang Xuezheng of his leadership roles and placed the subsidiary's shares into a third-party trust. This legal maneuver left Wingtech in the paradoxical position of 'ownership without power,' holding nearly 100% of the equity while possessing zero voting rights or operational oversight.
The domestic fallout has been equally devastating. Because Wingtech can no longer access Nexperia’s financial records or IT systems, its auditors issued a 'disclaimer of opinion' on the 2025 annual report. This regulatory red flag triggered an immediate 'Special Treatment' (*ST) status on the Shanghai Stock Exchange, signaling imminent delisting risk. Following the announcement, the stock endured 11 consecutive days of limit-down trading, leaving 250,000 retail investors trapped in a collapsing asset.
In May 2026, Wingtech launched a counter-offensive, filing an 8-billion-yuan lawsuit to reclaim its rights. The company alleges that Nexperia’s local management has unilaterally locked them out of all internal systems and refused to provide essential financial data since September 2025. This legal stalemate highlights the extreme vulnerability of cross-border acquisitions when geopolitical friction overrides international commercial law, turning a strategic asset into a stranded one.